Visual snow syndrome after start of citalopram-novel insights into underlying pathophysiology
- PMID: 32939564
- PMCID: PMC7803695
- DOI: 10.1007/s00228-020-02996-9
Visual snow syndrome after start of citalopram-novel insights into underlying pathophysiology
Conflict of interest statement
OE Eren has received honoraria for consulting within the past three years from Novartis Pharma. FS has nothing to report. CJ Schankin has received honoraria for consulting and lectures within the past 3 years from Novartis, Eli Lilly, Allergan, Almirall, Amgen, Teva Pharmaceuticals, MindMed, and Grünenthal outside the submitted work. AS has received honoraria for consulting and lectures within the past 3 years from Allergan Pharma, Bayer, Lilly, Novartis Pharma, Sanofi, and TEVA.
